Invea Therapeutics, Inc. (INAI)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	n/a
Revenue (ttm)	n/a
Net Income (ttm)	-8.05M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About INAI

Invea Therapeutics is a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs. Our aim is to develop oral, safe and effective small molecule therapies that control inflammation, prevent tissue damage, improve quality of life and achieve long-term disease remission. Our drug discovery and development approach combines artificial intelligence and machine learning with our team’s extensive experience and expertise, to decode the mechanisms and pathways that drive the initiation and pr...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2021
• Employees: 7
• Stock Exchange: NASDAQ
• Ticker Symbol: INAI
• Website: https://inveatx.com/